As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Life Sciences Sector Advisor, Karen Baldry, to discuss the trends she sees being the most impactful in 2021. The episode opens with a discussion of the COVID-19 vaccine and the shift in focus from clinical trials to supply, distribution, pricing, and access (01:15). Even after a vaccine is available, life sciences organizations will likely still see long term impacts of the pandemic across the business (01:52), with digital becoming an increasing area of concentration and innovation (02:15). The conversation then moves to the impact of these trends (03:00), including changes to future vaccine and drug development, interactions with HCPs (04:05), and investment in omnichannel (5:04). The interview closes with the hope that learnings from 2020 unlock new opportunities for life sciences companies and organizations across the entire healthcare industry (6:09).
Developing a Compelling Go-to-Market Strategy in Home & Community-Based Care
A large home and community-based care provider saw an opportunity to distinguish itself in a highly fragmented market as the preferred joint venture partner to health systems looking to adopt a transformative post-acute strategy. Read how Vynamic created a go-to-market strategy that positioned this client at the forefront of a shift towards high quality, home-based care, all while reducing the total cost of care.
The Elevation of Market Access
Trending News – Sept 22, 2022
Spotlight: Social Determinants of Health – September 15, 2022
European Medical Affairs Transformation Journey
Medical Affairs plays a critical role in key activities for pharmaceutical companies. This includes evidence generation, evidence dissemination, and very importantly, engagement with Healthcare Professionals. Read how Vynamic's client, the Global Head of Medical Affairs for a pharmaceutical company based in Europe, partnered with Vynamic to identify and define the strategic vision and priorities for their Region Europe Medical Affairs strategic transformation.
Creating A Global Medical Affairs Governance Roadmap
A global pharmaceutical company based in Europe needed to ensure robust and consistent product launch execution by Medical Affairs teams across multiple countries. Read how this client partnered with Vynamic to improve launch planning and efficiency and develop a high-impact roadmap that provided a flexible and repeatable model for their European Medical Affairs teams.
- Life Sciences
Integrated Business Planning in Life Sciences – September 8, 2022
Aligning Leadership Styles to Drive Medical Strategy
The US medical leadership team of a global life sciences company was faced with competing objectives that made it difficult to align on their team’s priorities. Based on these objectives, Vynamic planned and facilitated a tailored two-day workshop to help the leaders understand and leverage the power of their individual styles and collaborate more cohesively around a common strategy and clear priorities.
Building Culture & Strategy Through Cross-Functional Collaboration
Organizational changes at a rapidly growing, midsize life sciences company brought together employees from several functions to create a newly aligned business unit. With a lack of shared culture and misalignment around roles and responsibilities, a Vynamic workshop helped to bring this new business unit together to create a foundation of culture and clarity around ownership and ways of working.
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.